Danaher Corporation (DHR) Q1 2025 10-Q Quarterly Report
Filed: Apr 22, 2025Period ending Mar 28, 2025
Health Care
Industrial Instruments For Measurement, Display, and ControlSEC EDGAR Danaher Corporation (DHR) 10-Q quarterly report for Q1 2025, filed with SEC EDGAR on Apr 22, 2025 for the fiscal period ending Mar 28, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
Danaher Corporation Q1 2025 10-Q Analysis
Risk Factors
- • Newly added trade tariff risk triggered by recent U.S. and retaliatory tariffs with China, increasing supply costs and potentially reducing product demand
- • Materially updated supply chain risk due to ongoing tariffs causing potential product availability issues and operational disruptions
Danaher Corporation Q1 2025 Quarterly FinancialsXBRL
Revenue
$5.7B
▼ -0.9% YoY
Net Income
$954M
▼ -12.3% YoY
Gross Margin
61.2%
▲ +99bp YoY
Operating Margin
22.2%
▼ -45bp YoY
Net Margin
16.6%
▼ -215bp YoY
EPS (Diluted)
$1.32
▼ -9.0% YoY
Operating Cash Flow
$1.3B
▼ -25.3% YoY
Source: XBRL data from Danaher Corporation Q1 2025 10-Q filing on SEC EDGAR. All figures in USD.
Other Danaher Corporation Quarterly Reports
Get deeper insights on Danaher Corporation
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.